SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19
- PMID: 34414888
- PMCID: PMC8504968
- DOI: 10.7554/eLife.70458
SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19
Abstract
Background: Previously, we conducted a systematic review and analyzed the respiratory kinetics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Chen et al., 2021). How age, sex, and coronavirus disease 2019 (COVID-19) severity interplay to influence the shedding dynamics of SARS-CoV-2, however, remains poorly understood.
Methods: We updated our systematic dataset, collected individual case characteristics, and conducted stratified analyses of SARS-CoV-2 shedding dynamics in the upper (URT) and lower respiratory tract (LRT) across COVID-19 severity, sex, and age groups (aged 0-17 years, 18-59 years, and 60 years or older).
Results: The systematic dataset included 1266 adults and 136 children with COVID-19. Our analyses indicated that high, persistent LRT shedding of SARS-CoV-2 characterized severe COVID-19 in adults. Severe cases tended to show slightly higher URT shedding post-symptom onset, but similar rates of viral clearance, when compared to nonsevere infections. After stratifying for disease severity, sex and age (including child vs. adult) were not predictive of respiratory shedding. The estimated accuracy for using LRT shedding as a prognostic indicator for COVID-19 severity was up to 81%, whereas it was up to 65% for URT shedding.
Conclusions: Virological factors, especially in the LRT, facilitate the pathogenesis of severe COVID-19. Disease severity, rather than sex or age, predicts SARS-CoV-2 kinetics. LRT viral load may prognosticate COVID-19 severity in patients before the timing of deterioration and should do so more accurately than URT viral load.
Funding: Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant, NSERC Senior Industrial Research Chair, and the Toronto COVID-19 Action Fund.
Keywords: COVID-19 severity; SARS-CoV-2 replication; epidemiology; global health; infectious disease; infectious disease epidemiology; microbiology; none; pathogenesis of severe COVID-19; pediatric infections; prognostic indicator.
© 2021, Chen et al.
Conflict of interest statement
PC, NB, ZP, MK, FG No competing interests declared, DF reports serving on advisory boards of Seqirus, Sanofi Pasteur, Pfizer, and AstraZeneca, and consulting for the Ontario Nurses Association, Elementary Teachers' Federation of Ontario, JP MorganChase, WE Foundation, and Farallon Capital, outside the submitted work.
Figures
Similar articles
-
Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.Elife. 2021 Apr 16;10:e65774. doi: 10.7554/eLife.65774. Elife. 2021. PMID: 33861198 Free PMC article.
-
Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19.Int J Infect Dis. 2021 Jan;102:10-13. doi: 10.1016/j.ijid.2020.10.040. Epub 2020 Oct 25. Int J Infect Dis. 2021. PMID: 33115679 Free PMC article.
-
SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients.Crit Care. 2020 Oct 16;24(1):610. doi: 10.1186/s13054-020-03323-5. Crit Care. 2020. PMID: 33066801 Free PMC article.
-
Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019.J Microbiol Immunol Infect. 2020 Jun;53(3):473-480. doi: 10.1016/j.jmii.2020.03.021. Epub 2020 Mar 28. J Microbiol Immunol Infect. 2020. PMID: 32276848 Free PMC article. Review.
-
Gastrointestinal viral shedding in children with SARS-CoV-2: a systematic review and meta-analysis.World J Pediatr. 2022 Sep;18(9):582-588. doi: 10.1007/s12519-022-00553-1. Epub 2022 Jun 4. World J Pediatr. 2022. PMID: 35665477 Free PMC article. Review.
Cited by
-
The RdRp genotyping of SARS-CoV-2 isolated from patients with different clinical spectrum of COVID-19.BMC Infect Dis. 2024 Mar 4;24(1):281. doi: 10.1186/s12879-024-09146-x. BMC Infect Dis. 2024. PMID: 38439047 Free PMC article.
-
Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation.Nat Commun. 2023 Dec 16;14(1):8377. doi: 10.1038/s41467-023-43706-0. Nat Commun. 2023. PMID: 38104114 Free PMC article.
-
Digital PCR to Measure SARS-CoV-2 RNA, Variants, and Outcomes in Youth.J Pediatric Infect Dis Soc. 2023 Dec 16;12(12):618-626. doi: 10.1093/jpids/piad101. J Pediatric Infect Dis Soc. 2023. PMID: 37956414 Free PMC article.
-
Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients.Heliyon. 2023 Aug 22;9(9):e19373. doi: 10.1016/j.heliyon.2023.e19373. eCollection 2023 Sep. Heliyon. 2023. PMID: 37662725 Free PMC article.
-
Sex difference in the discordance between Abbott Architect and EuroImmun serological assays.PeerJ. 2023 Jul 17;11:e15247. doi: 10.7717/peerj.15247. eCollection 2023. PeerJ. 2023. PMID: 37483960 Free PMC article.
References
-
- Argyropoulos KV, Serrano A, Hu J, Black M, Feng X, Shen G, Call M, Kim MJ, Lytle A, Belovarac B, Vougiouklakis T, Lin LH, Moran U, Heguy A, Troxel A, Snuderl M, Osman I, Cotzia P, Jour G. Association of initial viral load in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with outcome and symptoms. The American Journal of Pathology. 2020;190:1881–1887. doi: 10.1016/j.ajpath.2020.07.001. - DOI - PMC - PubMed
-
- Bal A, Brengel-Pesce K, Gaymard A, Quéromès G, Guibert N, Frobert E. Clinical and Microbiological Assessments of COVID-19 in Healthcare Workers: A Prospective Longitudinal Study. medRxiv. 2020 doi: 10.1101/2020.11.04.20225862. - DOI
-
- Benotmane I, Gautier-Vargas G, Wendling MJ, Perrin P, Velay A, Bassand X, Bedo D, Baldacini C, Sagnard M, Bozman DF, Della-Chiesa M, Solis M, Gallais F, Cognard N, Olagne J, Delagrèverie H, Gontard L, Panaget B, Marx D, Heibel F, Braun-Parvez L, Moulin B, Caillard S, Fafi-Kremer S. In-depth virological assessment of kidney transplant recipients with COVID-19. American Journal of Transplantation. 2020;20:3162–3172. doi: 10.1111/ajt.16251. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- Vanier Scholarship (608544)/Natural Sciences and Engineering Research Council of Canada
- Canadian COVID-19 Rapid Research Fund (OV4-170360)/CIHR/Canada
- Senior Industrial Research Chair/Natural Sciences and Engineering Research Council of Canada
- Canadian COVID-19 Rapid Research Fund (OV4-170360)/CIHR/Canada
- COVID-19 Immunity Task Force/Public Health Agency of Canada
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
